 one of them for some car and k assets which expand the portfolio we believe natural killer cells and gamma delta cells play really really well together and that's sort of proven scientifically and then we recently announced a non-binding ly for another company that expands our car expertise and not just alpha betas but gamma delta cells so now we're in solid tumors we're in blood cancer we're in autoimmune it's it's really exploding and